Establishment of a Secretory Protein-Inducible CRISPR/Cas9 System for Nosema bombycis in Insect Cells

被引:0
|
作者
Fang, Wenxuan [1 ]
Zhou, Liang [2 ]
Deng, Boyuan [1 ]
Guo, Binyu [1 ]
Chen, Xue [1 ]
Chen, Peng [1 ,2 ]
Lu, Cheng [1 ,3 ]
Dong, Zhanqi [1 ,3 ]
Pan, Minhui [1 ,3 ]
机构
[1] Southwest Univ, State Key Lab Resource Insects, Chongqing 400716, Peoples R China
[2] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources Yu, Kunming 650091, Peoples R China
[3] Southwest Univ, Key Lab Sericultural Biol & Genet Breeding, Minist Agr & Rural Affairs, Chongqing 400716, Peoples R China
基金
国家重点研发计划;
关键词
CRISPR/Cas9; inducible gene editing; microsporidia; N; bombycis; NB29; CRISPR-CAS9; SYSTEM; GENOME; SEQUENCE;
D O I
10.1021/acs.jafc.3c08647
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Gene editing techniques are widely and effectively used for the control of pathogens, but it is difficult to directly edit the genes of Microsporidia due to its unique spore wall structure. Innovative technologies and methods are urgently needed to break through this limitation of microsporidia therapies. Here, we establish a microsporidia-inducible gene editing system through core components of microsporidia secreted proteins, which could edit target genes after infection with microsporidia. We identified that Nosema bombycis NB29 is a secretory protein and found to interact with itself. The NB29-N3, which lacked the nuclear localization signal, was localized in the cytoplasm, and could be tracked into the nucleus after interacting with NB29-B. Furthermore, the gene editing system was constructed with the Cas9 protein expressed in fusion with the NB29-N3. The system could edit the exogenous gene EGFP and the endogenous gene BmRpn3 after overexpression of NB29 or infection with N. bombycis.
引用
收藏
页码:13175 / 13185
页数:11
相关论文
共 50 条
  • [21] Mechanisms of the Specificity of the CRISPR/Cas9 System in Genome Editing
    Kulishova, L. M.
    Vokhtantsev, I. P.
    Kim, D. V.
    Zharkov, D. O.
    MOLECULAR BIOLOGY, 2023, 57 (02) : 258 - 271
  • [22] Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system
    Madhi, Zaid Saad
    Shallan, Mohammed Ali
    Almaamuri, Abdulhusein Mizhir
    Alhussainy, Ammar Abbas
    AL-Salih, Sadiq Salam S.
    Raheem, Abdulla K.
    Alwan, Hameed Jassem
    Jalil, Abduladheem Turki
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 78
  • [23] Therapeutic applications of CRISPR/Cas9 system in gene therapy
    Mollanoori, Hasan
    Teimourian, Shahram
    BIOTECHNOLOGY LETTERS, 2018, 40 (06) : 907 - 914
  • [24] Photoactivatable CRISPR/Cas9 System
    Akhmetova, E. A.
    Golyshev, V. M.
    Vokhtantcev, I. P.
    Meschaninova, M., I
    Venyaminova, A. G.
    Novopashina, D. S.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2021, 47 (02) : 496 - 504
  • [25] Decrypting the mechanistic basis of CRISPR/Cas9 protein
    Panda, Gayatri
    Ray, Arjun
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2022, 172 : 60 - 76
  • [26] CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein
    Tang, Lichun
    Zeng, Yanting
    Du, Hongzi
    Gong, Mengmeng
    Peng, Jin
    Zhang, Buxi
    Lei, Ming
    Zhao, Fang
    Wang, Weihua
    Li, Xiaowei
    Liu, Jianqiao
    MOLECULAR GENETICS AND GENOMICS, 2017, 292 (03) : 525 - 533
  • [27] Reversible Regulation of Polyubiquitin Gene UBC via Modified Inducible CRISPR/Cas9 System
    Han, Seung-Woo
    Jung, Byung-Kwon
    Park, So-Hyun
    Ryu, Kwon-Yul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13):
  • [28] Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells
    Voets, Olaf
    Tielen, Frans
    Elstak, Edo
    Benschop, Julian
    Grimbergen, Max
    Stallen, Jan
    Janssen, Richard
    van Marle, Andre
    Essrich, Christian
    PLOS ONE, 2017, 12 (08):
  • [29] Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
    Lin, Yao
    Wu, Jiahua
    Gu, Weihuai
    Huang, Yulei
    Tong, Zhongchun
    Huang, Lijia
    Tan, Jiali
    ADVANCED SCIENCE, 2018, 5 (04):
  • [30] Advances in Optical Regulation of the CRISPR/Cas9 System
    Xue, Yuwen
    Li, Lei
    Li, Meixing
    Shen, Qingming
    ACTA CHIMICA SINICA, 2024, 82 (11) : 1180 - 1192